O
Outcomes4Me
Biotech & Life Sciences · Cambridge, United States · Founded 2017
On a mission to improve health outcomes by empowering patients with understandable, relevant, and evidence-based information MoreLess
Outcomes4Me is a pioneering healthcare technology company that offers an award-winning app designed to support cancer patients. The app provides free access to evidence-based resources and oncologist-approved guidance, helping patients manage their treatment options, stay updated with the latest research, and track symptoms or medications. Outcomes4Me primarily serves cancer patients, particularly those dealing with breast cancer, by integrating with the NCCN Clinical Practice Guidelines in Oncology, a set of guidelines developed by a not-for-profit alliance of 33 leading cancer centers. The company operates in the digital health market, focusing on patient empowerment and improved quality of life through technology. Outcomes4Me's business model revolves around offering a free app to patients while potentially partnering with healthcare providers, pharmaceutical companies, and research institutions for revenue generation. The company makes money through these partnerships, which may include data sharing agreements, sponsored content, or premium services for healthcare professionals. Keywords: cancer support, patient empowerment, digital health, oncology guidelines, breast cancer, evidence-based resources, symptom tracking, FDA-approved, healthcare technology, patient community.
Company overview
Outcomes4Me company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Cambridge, United States
- Employees
- 33
- Open positions
- 8
- Dealroom signal
- 88.7
- Investment activity
- 2 companies · latest May 2026
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Outcomes4Me funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2025 | $21M | $84M | Northpond Ventures · Forecast Labs · Sierra Ventures · LabCorp | ↗ |
| EARLY VC✓Equity / VC | Sep 2023 | $0 | — | Forecast Labs · LabCorp | ↗ |
| SERIES A✓Equity / VC | Apr 2021 | $12M | $48M | Sierra Ventures · Asset Management Ventures · Merstal Ltd · Northpond Ventures | — |
| EARLY VC✓Equity / VC | Nov 2020 | $4.7M | $19M | Sierra Ventures · Asset Management Ventures · National Cancer Institute SBIR Development Center · Merstal Ltd | — |
| SEED✓Equity / VC | Jan 2020 | $2.3M | $9.2M | Undisclosed | — |
| CONVERTIBLE✓Equity / VC | Jan 2020 | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 34 |
| 2025 | 30 |
| 2024 | 32 |
| 2023 | 26 |
| 2022 | 41 |
| 2021 | 18 |
| 2020 | 13 |
Growth signals
Outcomes4Me website traffic
Latest recorded traffic for Outcomes4Me is 48K monthly website visits, up 37.1% over the last three months. Outcomes4Me's team grew 10% over the past year.
Hiring
Open positions at Outcomes4Me
Current openings linked to this company in Dealroom.
Comparisons
Outcomes4Me compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Outcomes4Me investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Geno.MeMadison, United StatesThe world's first searchable ecosystem of linked genetic and medical data
$8.8Mvaluation
RealyzePittsburgh, United StatesCombining the latest in AI technology with clinical expertise to provide better healthcare insights and drive outcomes
→
Talent graph
Outcomes4Me's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Outcomes4Me has talent and traffic
team presence
In the news
Latest news about Outcomes4Me
Recent press, funding announcements, and product moves mentioning Outcomes4Me — open to read from the original sources.
Market sentiment
What the market is saying about Outcomes4Me
An AI-synthesized read of the highest-engagement posts about Outcomes4Me on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Outcomes4Me’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.